APA(7版)引用形式

Hengeveld, P. J., Schilperoord-Vermeulen, J., Kolijn, P. M., Dubois, J. M. N., Westerweel, P. E., Kersting, S., . . . Langerak, A. W. (2025). Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients. Nature Publishing Group.

Chicagoスタイル(17版)引用形式

Hengeveld, Paul J., Joyce Schilperoord-Vermeulen, P. Martijn Kolijn, Julie M. N. Dubois, Peter E. Westerweel, Sabina Kersting, Arnon P. Kater, Mark-David Levin, , Anton W. Langerak. Treatment with Obinutuzumab Plus Venetoclax Reshapes the TRB Repertoire of CLL Patients. Nature Publishing Group, 2025.

MLA(9版)引用形式

Hengeveld, Paul J., et al. Treatment with Obinutuzumab Plus Venetoclax Reshapes the TRB Repertoire of CLL Patients. Nature Publishing Group, 2025.